Europe
Auris Medical Holding AG announced its intention to relocate the Company’s domicile from Zug, Switzerland to Hamilton, Bermuda.
Rentschler Biopharma SE appoints Dr. Christian Hunzinger as Senior Vice President Project Management
Rentschler Biopharma SE announced the appointment of Dr. Christian Hunzinger (48) as the new Senior Vice President Project Management, effective from January 15, 2019.
Companies are filling in the gaps and the entire area of so-called “liquid biopsies” is hot these days, with companies like Guardant Health, Karius, Freenome, Apostle and GRAIL Bio entering the market. With this backdrop, let’s look at some companies working in the same field as the now-defunct Theranos.
First U.S. Patients Treated Using Mazor X Stealth(TM) Edition at Norton Healthcare and Reston Hospital Center
Here’s a look at this week’s calendar for decisions coming down from the U.S. Food and Drug Administration (FDA).
On Thursday, regulators with both the FDA and EMA announced that patients prescribed the drug should ask their doctors if it is wise to continue taking it. This comes after Lartruvo failed to hit endpoints in a Phase III study of advanced or metastatic soft tissue sarcoma.
This week, the U.S. Supreme Court rejected Swiss pharmaceutical company Helsinn Healthcare S.A.’s claim that Teva Pharmaceutical violated patent rights when the Israel-based company released a generic version of its anti-nausea medicine, Aloxi.
As the United Kingdom nears closer and closer to exiting the European Union without a deal, drug manufacturers like Novartis are preparing contingencies for how they will continue to provide medications, many of them life-saving, for patients in the U.K.
DiamondTemp Ablation System Represents Disruptive RF Innovation
Main5 expert panel: Launch medications faster and at lower cost despite stricter formalities
PRESS RELEASES